Skip to content

Screener Atlas Counties Economy Valuation Saved

For research and education only. Not financial advice. Nothing on TickerFacts recommends buying, selling or holding any investment. Read the limitations · Terms of use

OnKure Therapeutics, Inc. (OKUR) › Revenue

OnKure Therapeutics, Inc. (OKUR): Revenue

Annual figures by period end, from SEC filings.

$0

Year ended 2024-12-31

Period ended	Revenue	Change YoY	Source filing
2024-12-31	$0	n/a	2025-03-10, From 2024-01-01

Other metrics: R&D Expense Operating Income Depreciation & Amortization EBITDA Net Income EPS (Diluted)Total Assets Total Liabilities Shareholders' Equity Cash & Equivalents Operating Cash Flow Capital Expenditures Free Cash Flow Share Repurchases Shares Outstanding Weighted Average Diluted Shares EPS (Basic)

A clearer view of the business behind the ticker.

API & developers Sources & coverage Terms of use Source: SEC EDGARNot financial or investment advice.